Invention Grant
- Patent Title: Functionalized exendin-4 derivatives
-
Application No.: US14135801Application Date: 2013-12-20
-
Publication No.: US09670261B2Publication Date: 2017-06-06
- Inventor: Torsten Haack , Michael Wagner , Bernd Henkel , Siegfried Stengelin , Andreas Evers , Martin Lorenz , Katrin Lorenz
- Applicant: Sanofi
- Applicant Address: FR Paris
- Assignee: SANOFI
- Current Assignee: SANOFI
- Current Assignee Address: FR Paris
- Agency: Lathrop & Gage LLP
- Agent James H. Velema, Esq.
- Priority: EP12306647 20121221
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61K45/00 ; A61P25/00 ; A61P3/04 ; A61P3/06 ; A61P3/10 ; A61P9/00 ; A61P9/10 ; A61P9/12 ; C07K14/575 ; C07K14/605 ; A61K38/26 ; A61K45/06 ; A61K38/28 ; A61K38/22
Abstract:
The present invention relates to exendin-4 derivatives and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as reduction of excess food intake.
Public/Granted literature
- US20140206609A1 Functionalized Exendin-4 Derivatives Public/Granted day:2014-07-24
Information query
IPC分类:
